Skip to main content
ConductScienceScienceDex

David Sultzer

NIH Rank #2820
Unclaimed recordClaim profile
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 16426056Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$2.1M
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#2,820
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for David Sultzer. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing David Sultzer as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG074983-05R01
    Safety/Tolerability/Immunogenicity of first-in-human Aβ DNA vaccine, AV-1959D Phase 1 trials in early-stage AD subjects: based on IND18953 cleared by FDA.
    Institute for Molecular Medicine
    $2.1M
    award amount

Award organization

Organizations that administered FY2026 awards listing David Sultzer as a PI.

FY2026 award administered by Institute for Molecular Medicine (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Institute for Molecular Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4036
  6. 2024
    Entered Top 25% Nationally
    Ranked #4036
  7. 2025
    $5M Cumulative Funding
  8. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as David Sultzer.

Lon S Schneider
Institute for Molecular Medicine
3
shared awards
Michael G Agadjanyan
Institute for Molecular Medicine
3
shared awards
Craig E Stark
University of California-Irvine
2
shared awards
Daniel L Gillen
University of California-Irvine
2
shared awards
Edwin S Monuki
University of California-Irvine
2
shared awards
Elizabeth Head
University of California-Irvine
2
shared awards
Frank M Laferla
University of California-Irvine
2
shared awards
Ira T. Lott
University of California-Irvine
2
shared awards
Joshua Grill
University of California-Irvine
2
shared awards
Maria Corrada
University of California-Irvine
2
shared awards

Explore further

Find collaborators for David Sultzer

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →